Cost-Effective Range of 48-Hour Pre-Qualified Temperature Controlled Shippers

In biotechnology, Generis, generis group, healthcare technology, Life sciences, manufacturing, manufacturing operations, medical device, pharmaceutical by Generis0 Comments

Using just three types of refrigerants and four shippers to create 12 solutions, the Certis® 2-Day Platform maximizes the number of solutions while minimizing the number of components. The new platform is sized to accommodate 7, 13, 27 and 56 liters of product. Each of the new solutions feature a year round pack-out designed for use in both hot and cold seasons.

To learn more about qualified temperature controlled shippers, check out this article by Sonoco!

Certis-NEW-Hero.jpg

Smart Outsourcing: Strategic Alignment, Risk Management, and New Relationships

In biomanufacturing, healthcare technology, Life sciences, logistics, manufacturer, manufacturing, marketing, medical device, pharmaceutical, technology by Generis0 Comments

Outsourcing in the pharmaceutical industry, until recently, has been largely confined to commercial manufacturing, packaging, and support for clinical trials. The industry is rapidly changing; companies are facing rising costs, a fast evolving global market, and weak pipelines. Many companies are outsourcing activities that have historically been kept in house, freeing themselves to concentrate on their core competencies and become more agile in responding to changing conditions. These new outsourcing models include discovery and R&D, regulatory, chemistry and manufacturing controls (CMC) support, and back office sales and marketing activities—virtually no activity is out of bounds. Instead of building or acquiring specialized technologies and facilities, many companies are seeking access to them elsewhere. Smart outsourcing provides the following operational and business benefits:

To learn more about smart outsourcing and what the operational and business benefits are, check out this white paper by OQSIE 

bfsbfs

Are You Forgetting Something In Your Single-Use Strategy?

In biomanufacturing, biotechnology, Generis, generis group, innovation, manufacturer, manufacturing, manufacturing operations, system design by Generis0 Comments

In your experience, what has the outcome been like when an organization has taken the time to improve its’ single-use strategy?

The first thing people sigh in relief about is that there is no danger of breathing in particles and that they are dispersing all over the manufacturing facility. Once the system is closed, there is no longer so much time spent on cleaning and validation. In addition, it helps speed up the process making it so there is one less bottleneck on the road to continuous manufacturing.

To learn more about single-use strategy and make sure you are including everything you need, check out the full ebook by ILC Dover below! 

fefefw

Understanding the Hidden Costs of Weak GMP Documentation and the Return on Investment for Strong GMP Documentation

In biomanufacturing, business, Generis, generis group, manufacturing, pharmaceutical, production efficiency by Generis0 Comments

In your experience, when an organization has invested in proper documentation, what have the results been like?

The results have been tremendous!

We’ve seen organizations move away from poor compliance and low morale toward a quality mindset with excitement for innovation. We’ve opened career paths for promising writers who love challenge and have a desire to help patients through strong GMP documentation. Our clients have demonstrated returns on investment for our projects by lowering documentation-based costs, reducing turnaround times, reducing documentation-based errors, and shortening regulatory filing times. Documentation comes off the critical path for the first time! Lastly, we’ve seen our projects serve as a springboard for further innovation and enhancements.

In a nutshell, our best results have been realized when GMP documentation is embraced as an opportunity and powerful mechanism to help companies advance new therapies for their patients.

To learn more about GMP documentation, check out the ebook by Bulletproof below! 

sdwqdwq

Boost Profits with EZ BioPac® Single-Use Powder Transfer

In manufacturing by Generis0 Comments

Today, manufacturers are optimizing open-suite facility design to maximize throughput and profitability. Key to this initiative is minimizing product loss due to feedstock spills, waste and cross contamination. Improving the safety of workers is also a driving factor, through reduced exposure 10 to airborne particles and lowering the risk of particle ignition. In order to accomplish both, a highly efficient powder transfer and containment system is required — one that is designed exclusively for powders, not one adapted from a liquid transfer system.

The EZ BioPac® single-use system is the fastest, most efficient solution. Its larger diameter top opening permits easy filling and fine-tuning of final weight. It is suitable for a wide range of filling/ dispensing volumes, flow rates, and product weights. Plus, its rugged, disposable transfer bags feature anti-static properties, assuring fast, complete discharge into process vessels.

Want to learn more about the EZ BioPac Single-Use Powder Transfer and how it can boost profits? Check out the white paper from ILC Dover below!

csacsa

How to Boost Profits with Single-Use Powder Transfer in Biopharmaceuticals

In manufacturing by Generis0 Comments

Many biopharmaceutical manufacturers are Implementing single-use containment and transfer of media and buffer materials to prevent feedstock contamination and to promote worker safety. Choosing the proper containment system can have a significant impact on productivity and profitability.Solutions such as the EZ BioPac® system from ILC Dover® lessens the amount of powder that disperses into the air substantially, thereby lowering the risk of cross-contamination. Reducing the amount of contamination, in turn, reduces the time needed for changeover, lowers staff costs, and frees staff to work on more vital jobs, which all contribute to profitability.

Want to learn more about single use powder transfer? Read more in the white paper by ILC Dover below!

vdavds

CRYSTALOMICS: A PATHWAY FORWARD FOR PROTEIN CRYSTALLIZATION

In biomanufacturing, Generis, generis group, healthcare technology, Life sciences, logistics, manufacturing by Generis0 Comments

Protein-based therapeutics, specifically monoclonal antibodies (mAbs), have become the focus of pharmaceutical R&D over the last decade. While these biologics offer many possibilities when it comes to treating a variety of diseases, they also present considerable challenges during development.

All of these factors combined make manufacturing and delivery of protein-based therapeutics very difficult. If these drugs could be produced at lower viscosities, then a lower volume could be used, making subcutaneous delivery possible; this would also significantly reduce the risk of aggregates. Now, a treatment that typically requires an hour in a clinic could potentially become a simple injection at home.

This informative white paper by Althea covers the challenges of crystallization of proteins for therapeutic use and how to preserve efficiency during crystallization.

Learn more about a pathway forward for protein crystallization in the white paper below! 

fewfewf 

OQSIE: Quality by Design

In manufacturing by Generis0 Comments

This Q&A eBook with OQSIE will delve into:

  • three batch validation;
  • regulatory compliance in product development and quality systems; and
  • how to lead an integrated QbD implementation strategy.

OQSIE will also be discussing these topics at a Lunch & Learn at Generis’ American Biomanufacturing Summit taking place May 23-24th in San Diego, CA.

Read the full ebook in the link below!

http://bit.ly/2qJZLiu

 dwdwq

Talk of the Trade: Heliae

In manufacturing by Generis0 Comments

Dan Simon, President & CEO of Heliae Tech. Holdings Inc. discusses the last 5 years of the company and creating a platform to grow economically viable algae.  Now they are applying it into four basic categories; Therapeutic drugs, Cosmetics, Nutraceuticals and Agriscience.

View the full video below!

Managing Your Cold Supply Chain to Ensure Your Vaccinations Get to Where They’re Needed Most

In biomanufacturing, Generis, generis group, healthcare technology, innovation, Life sciences, logistics, manufacturing, mfg, pharmaceutical, production efficiency, supply chain, technology, testing by Generis0 Comments

World Courier is transporting Zika diagnostic test kits to and from South America.

Companies trust us to transport and store time- and temperature-sensitive products, and the urgent and sensitive Zika diagnostic test kits are no exception! In the midst of concerns, especially for the well-being of athletes, World Courier’s capability and expertise are another reason to have peace of mind.

The Zika virus was a huge fear for the 2016 Olympic summer games in Rio de Janeiro, Brazil. In the white paper below, World Courrier explains the process and challenges of transporting Zika tests for the 2016 Olympic games to ensure the safety of the Olympic athletes and those attending.

Take a look at the full white paper below!

feadfafa